GSK137647A
From Wikipedia, the free encyclopedia
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C16H19NO3S |
| Molar mass | 305.39 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
GSK137647A (also called GSK137647) is an experimental drug which acts as a highly selective and moderately potent agonist for the free fatty acid receptor FFAR4 (GPR120).[1] It has antiinflammatory effects[2] and has been used to research the role of FFAR4 in various processes such as diabetes,[3][4] ulcerative colitis,[5] maintenance of bone density,[6] and cancer.[7]